Is Nutanix the Best Comeback Trade Left in 2025? The Setup Says Yes

Nutanix shares have plunged roughly 40% from September highs and more than 20% in the past three weeks after a late-November earnings report that missed revenue and trimmed forward guidance, but management says the shortfall reflected deals that closed late with future start dates (timing that delayed revenue recognition) while free cash flow remained intact. Technical indicators show selling may be exhausted—RSI rising from oversold levels and a bullish MACD crossover with a stabilizing floor since early December—while analysts including Needham (Buy, PT $65) and Morgan Stanley (Overweight, PT $82) continue to view the miss as timing-driven rather than demand-driven. If consolidation holds, the risk/reward looks favorable for a year-end rebound, though the reduced guidance still represents a near-term execution risk to monitor.

Analysis

Shares of Nutanix (NTNX) closed just under $48 last week, roughly 40% below September highs and more than 20% down over the past three weeks after a late‑November earnings release. The report combined a revenue miss and a trimmed forward guidance, prompting a gap down that drove the stock about 20% below its pre‑earnings price to levels near where it started last year.

Management attributed the revenue shortfall to deals that closed late with future start dates that deferred revenue recognition, while free cash flow remained intact and the quarter was described as the company's best‑ever from a revenue‑booked perspective. Analysts have largely treated the miss as timing‑driven: Needham reiterated Buy with a $65 target and Morgan Stanley stayed Overweight with an $82 target (implying roughly 70% upside).

Technical indicators suggest selling pressure may be exhausted—RSI is rebounding from extremely oversold levels, the MACD just had a bullish crossover, and bears have been unable to push the stock below early‑December lows—supporting a consolidation or pre‑rally setup. The primary near‑term risk is persistent guidance or execution weakness; sentiment is mildly positive (signal 0.3) and market‑impact metrics are modest, which favors a tactical rebound but with elevated volatility.

Key Decisions for Investors

• Consider initiating a modest, size‑limited long position or add incrementally on confirmed dips given the management explanation that timing, not demand, drove the miss and analyst targets imply material upside
• Apply disciplined risk management by setting a stop‑loss below the early‑December floor and capping position size to reflect guidance uncertainty and elevated near‑term volatility
• Monitor next quarter revenue recognition and any further guidance revisions as the key catalysts to add to or trim exposure, and consider using defined‑risk option structures (e.g., vertical call spreads) if you want upside exposure with limited downside